# Advisor Review - Gemini-3-Flash

**Role:** Academic advisor checking for fatal errors
**Model:** gemini-3-flash-preview (ai_studio)
**Paper:** paper.pdf
**Timestamp:** 2026-03-03T05:19:45.889909
**Route:** Direct Google API + PDF
**Paper Hash:** 91b12b0d7724c606
**Tokens:** 26638 in / 471 out
**Response SHA256:** 936d69e47ac85d08

---

I have reviewed your draft paper, "The Welfare Cost of Prescription Drug Monitoring Programs: A Sufficient Statistics Approach," for fatal errors. 

**ADVISOR VERDICT: PASS**

I have checked the paper against the four critical categories:

1.  **Data-Design Alignment:** 
    *   Treatment years (2014–2019 for the main sample) are fully contained within the data coverage (2013–2023). 
    *   The CS-DiD estimator requirement for pre-treatment data is met by excluding early adopters from the main sample (Table 6). 
    *   Table 7 confirms the presence of post-treatment observations for all periods used in the aggregate ATT calculation.

2.  **Regression Sanity:**
    *   Standard errors and coefficients in Table 2, Table 4, and Table 7 are within plausible ranges for percentage point outcomes (mostly < 0.2).
    *   No R² values are reported as negative or >1.
    *   No "NA", "NaN", or "Inf" values appear in the results tables.

3.  **Completeness:**
    *   All regression tables (Table 2, Table 4) include sample sizes (N).
    *   Standard errors are reported for all point estimates.
    *   I found no placeholder text (e.g., "TBD", "XXX") in the final tables or text.

4.  **Internal Consistency:**
    *   The statistics cited in the Abstract and Introduction (e.g., aggregate ATT of -0.070, SE 0.102) match the results presented in Table 2 and Table 7.
    *   The sample period (2013–2023) is consistent across the data description, summary statistics (Table 1), and regression notes.
    *   The critical threshold $\beta^* \approx 0.72$ is derived consistently in Section 7.2 and matches the value cited throughout the paper.

The paper is internally consistent and free of fatal empirical design errors. You may proceed with your submission.

**ADVISOR VERDICT: PASS**